Mach 1 Financial Group LLC Buys Shares of 3,244 Tenet Healthcare Corporation $THC

Mach 1 Financial Group LLC purchased a new position in Tenet Healthcare Corporation (NYSE:THC) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 3,244 shares of the company’s stock, valued at approximately $645,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Boston Partners grew its stake in shares of Tenet Healthcare by 38.8% in the third quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after acquiring an additional 880,413 shares during the last quarter. Ameriprise Financial Inc. raised its position in shares of Tenet Healthcare by 8.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock worth $373,020,000 after purchasing an additional 157,109 shares during the last quarter. AQR Capital Management LLC boosted its stake in Tenet Healthcare by 62.3% in the 3rd quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock worth $380,989,000 after purchasing an additional 720,160 shares in the last quarter. Eminence Capital LP bought a new stake in Tenet Healthcare during the 3rd quarter valued at about $225,263,000. Finally, Bank of America Corp DE raised its holdings in Tenet Healthcare by 9.6% in the third quarter. Bank of America Corp DE now owns 1,078,585 shares of the company’s stock worth $218,996,000 after buying an additional 94,903 shares during the last quarter. Institutional investors own 95.44% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on THC shares. Wells Fargo & Company cut their price target on shares of Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Cantor Fitzgerald reiterated an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. Leerink Partners boosted their price target on Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a research note on Friday, February 20th. Morgan Stanley set a $254.00 price target on Tenet Healthcare in a report on Friday, May 1st. Finally, UBS Group lifted their price objective on Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. Nineteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $244.16.

Tenet Healthcare Trading Down 5.0%

NYSE:THC opened at $177.96 on Friday. The company has a 50 day simple moving average of $195.29 and a two-hundred day simple moving average of $203.09. The company has a market cap of $15.33 billion, a PE ratio of 9.25, a price-to-earnings-growth ratio of 1.24 and a beta of 1.30. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. Tenet Healthcare Corporation has a 12 month low of $146.60 and a 12 month high of $247.21.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.21 by $0.61. The firm had revenue of $5.37 billion for the quarter, compared to the consensus estimate of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.During the same period last year, the business posted $4.36 EPS. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Research analysts forecast that Tenet Healthcare Corporation will post 17.64 earnings per share for the current year.

Insider Activity

In other Tenet Healthcare news, EVP Thomas W. Arnst sold 8,000 shares of the company’s stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $238.85, for a total transaction of $1,910,800.00. Following the completion of the sale, the executive vice president directly owned 12 shares of the company’s stock, valued at approximately $2,866.20. This represents a 99.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Paola M. Arbour sold 6,500 shares of the stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the completion of the transaction, the executive vice president owned 29,291 shares in the company, valued at $6,983,853.13. The trade was a 18.16% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 46,517 shares of company stock valued at $10,943,111 in the last quarter. 0.97% of the stock is currently owned by insiders.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.